Skip to main content
. 2022 Apr 7;13(4):9345–9356. doi: 10.1080/21655979.2022.2054195

Figure 3.

Figure 3.

Fraxetin down-regulates the expression of PLK4 and phosphorylated PI3K/Akt in DU145 prostate cancer cells. DU145 cells were treated with 0, 10, 20 and 40 μM Fraxetin for 48 h, then (a-b) PLK expression was detected by RT-qPCR and western blot assays; (c) protein expression of phosphorylated PI3K and Akt was measured by western blotting. **P < 0.01 and ***P < 0.001 vs Control.